Herber, Candice B.
Yuan, Chaoshen
Chang, Anthony
Wang, Jen-Chywan
Cohen, Isaac
Leitman, Dale C. http://orcid.org/0000-0003-3178-4904
Funding for this research was provided by:
National Institute on Aging (1 R43 AG072965-01)
National Institutes of Health (1 R43 DK109862-01, DK113019-01A1)
Article History
Received: 21 September 2021
Accepted: 6 April 2022
First Online: 25 April 2022
Declarations
:
: Not applicable.
: All authors read and approved the submission of this manuscript.
: CY, IC, and DCL are employees of Iaterion Inc., which is developing reprogramming compounds as drugs. The other authors declare no competing interests.